Dentatorubral-pallidoluysian Atrophy
📧 Sign up to get email alerts when something new happens for Dentatorubral-pallidoluysian Atrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Personalized Antisense Oligonucleotide Therapy for A Single Participant With ATN1 Gene Mutation [Phase 1, Phase 2]
A clinical trial update describes a personalized antisense oligonucleotide therapy being studied for a single participant with Dentatorubral…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Personalized Antisense Oligonucleotide for A Single Participant (nL62541) With ATN1 Gene Mutation [Phase 1, Phase 2]
Clinical trial update for a personalized antisense oligonucleotide targeting ATN1 (nL62541) in Dentatorubral-Pallidoluysian Atrophy; the Pha…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: CureDRPLA Global Patient Registry
A global CureDRPLA patient registry is recruiting to collect data on individuals with Dentatorubral-pallidoluysian atrophy (DRPLA).
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial of a personalized antisense oligonucleotide targeting ATN1 mutation for Dentatorubral-Pallidoluysian Atroph…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Dentatorubral-pallidoluysian Atrophy Natural History and Biomarkers Study
The study on natural history and biomarkers for Dentatorubral-pallidoluysian atrophy is currently recruiting at University College London.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.